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In the present study, the chemotherapeutic potential of zerumbone towards HeLa cell 
line and cervical cancer induced in female Balblc mice were investigated. The 
chemotherapeutic potential of zerumbone was compared with cisplatin, a commercial 
drug used to treat cervical cancer. The cytotoxicity of both zerumbone and cisplatin 
towards HeLa cell line were determined using MTT assay. The findings showed that the 
ICso value (* S.E.M) of zerumbone towards HeLa cell line was 11.3 * 0.2 pM, whilst 
the ICSO value of cisplatin was 7.5 * 0.3 pM. Both IC50 values for zerumbone and 
cisplatin fall within the very significant group based on the National Cancer Institute 
Standard. All the values are significant (P < 0.01). The HeLa cells were treated with 
ICso concentration of zerumbone and cisplatin respectively for morphological analysis 
using inverted microscopy. The results showed significant growth retardation in HeLa 
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cells exposed to zerumbone and cisplatin at 24,48 and 72 hours, whilst the control cells 
are well spread and confluent. Pregnant female Balblc mice were exposed to 
Diethylstilbestrol (DES) at 13 '~  to 1 8 ' ~  day of gestation. The progeny of the DES- 
exposed mothers developed cervical intra-epithelial neoplasia. These progenies were 
divided into 4 groups and were either given treatment with normal saline, 8 mglkg 
zerumbone, 16 mg/kg zerumbone and 10 mg/kg cisplatin. The mice were sacrificed 
following the treatments and their cervical tissues subjected to histological examination, 
TUNEL Assay and immunohistochemistry. The histological examination revealed that 
both zerumbone and cisplatin treatments were able to inhibit the progression of cervical 
dysplasia fiom becoming more severe dysplasia (CIN 3). In the mice treated with 
normal saline, the dysplasia had progressed to CIN 3 (severe dysplasia). The TUNEL 
assay micrographs showed that there was no apoptosis in the cervical tissue of the 
normal saline treated mice compared to the cervical tissue of mice treated with 
zerumbone and cisplatin, where abundant apoptotic cells were noticed. The levels of 
serum IL-6 were suppressed in mice treated with zerumbone and cisplatin. In contrast, 
mice treated with normal saline showed elevated level of serum IL-6. 
Immunohistochemistry study demonstrated that the production level of membrane 
bound IL-6 receptor had been suppressed by the treatment of zerumbone and cisplatin 
compared to mice treated with normal saline which had a higher concentration of 
membrane bound IL-6 receptors. This showed that both zerumbone and cisplatin act in 
a similar manner in vivo and in vitro. In conclusion, it is suggested that zerumbone, a 
plant derived compound, could be explored as a new anti cancer agent for treating 
cervical cancer in the future. 
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Dalam kajian ini, keupayaan kemoterapeutik zerwnbone terhadap sel selanjar kanser 
serviks (HeLa) dan tikus mencit Balb/c telah dikaji. Keupayaan terapeutik zerurnbone 
dibandingkan dengan cisplatin, dadah komersial bagi merawat kanser serviks. Kesan 
sitotoksik zerurnbone dan cisplatin terhadap sel HeLa dikaji dengan menggunakan asai 
MTT. Keputusan menunjukkan bahawa nilai ICso (A S.E.M) bagi zerumbone ialah 11.3 
k 0.2 pM, manakala bagi cisplatin ialah 7.5 A 0.3 pM. Nilai ICSo bagi zerumbone dan 
cisplatin adalah sangat signifikan berdasarkan garis panduan Institut Kanser Nasional. 
Semua nilai ICso adalah signifikan (P < 0.01). Sel HeLa dirawat dengan zerumbone dan 
cisplatin dengan nilai ICso masing-masing dan kajian morfologi dijalankan dengan 
bantuan mikroskopi inverted. Keputusan menunjukkan pertumbuhan sel pada jam ke- 
24, 48 dan 72 rawatan zerumbone dan cisplatin telah terbantut, manakala sel kawalan 
tumbuh dengan sihat dan tersebar luas. Dalam kajian in vivo, tikus.betina yang hamil 
diberi suntikan DES (Diethylstibestrol) pada hari gestasi 13 hingga 18. Progeni betina 
bagi ibu-ibu yang terdedah kepada DES, telah menggalakan pertumbuhan CIN 
(Cervical Intra-epithelial Neoplasia). Tikus- tikus betina yang telah terdedah kepada 
DES dalam rahim ibu dibahagikan kepada 4 kumpulan dan diberi rawatan dengan 
normal saline, 8 rnglkg zerumbone, 16 mglkg zerumbone dan 10 mgkg cisplatin. 
Tikus-tikus tersebut dibunuh dan tisu serviksnya dianalisis melalui kaedah histologi, 
asai TUNEL dan kaedah immunohistokimia. Kajian histologi menunjukkan zerumbone 
dan cisplatin dapat menghalang pertumbuhan CIN 1 (displasia awal) kepada CIN 3 
(displasia teruk) pada tisu serviks tikus. Manakala bagi tikus yang hanya diberi saline 
normal, penyakitnya (displasia) berkembang dan mencapai CW 3. Hasil kajian TUNEL 
asai menunjukkan tiada sel apoptosis diperhatikan dalam tisu serviks tikus yang dirawat 
dengan normal saline, manakala tikus yang dirawat dengan zerumbone dan cisplatin 
menunjukkan sel apoptosis yang banyak. Paras IL-6 darah bagi tikus yang dirawat 
dengan zerumbone dan cisplatin adalah sangat rendah berbanding tikus yang dirawat 
dengan normal saline dimana paras IL-6 adalah amat tinggi. Kajian immunohistokimia 
menunjukkan penghasilan reseptor IL-6 menurun pada tikus yang dirawat dengan 
zerumbone dan cisplatin, manakala tikus yang dirawat dengan normal saline 
menunjukkan peningkatan dalam penghasilan reseptor IL-6 secara mendadak. Kedua- 
dua zerumbone dan cisplatin bertindak pada kadar yang sama dalam kajian in vitro dan 
in vivo. Kesimpulannya zerumbone, sebatian semulajadi daripada tumbuhan 
dicadangkan untuk digunakan bagi menhasilkan ubatan alternatif untuk merawat kanser 
serviks pada masa hadapan. 
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CHAPTER 1 
INTRODUCTION 
Cervical cancer remains the second common cancer among women worldwide. It is, 
however, the most common cancer in women in developing countries accounting for 
80% of all cases. Majority of tumors in these women are diagnosed at advanced stages 
with a resulting high mortality (Rowlands and de Barros Lopez, 2001). Human 
papilloma virus (HPV) has been implicated as the primary causative agent for cervical 
squamous cancer, whereby 99.7% of all cervical cancers had been identified to have 
HPV DNA (Rowlands and de Barros Lopez, 2001). 
In 1943, Papanicolaou and Traut published their experience on the role of cervical 
cytology in identifLing cancer of the cervix. The technique known as Pap smear, was 
rapidly incorporated as a screening test for invasive and pre-invasive lesions (Rowlands 
and de Barros Lopez, 2001). Despite the success of the Papanicolou Smear (Pap smear), 
cervical carcinoma still causes high mortality but is treatable and curable if diagnosed at 
early stage. Moreover, the malignant transformation of cervical epithelial cells has been 
reported to have a long latency period of up to 10 years (Ho et al., 1998). 
To date, the most effective single chemotherapeutic agent for cervical carcinoma is 
cisplatin, which normally achieves a response rate of between 23% and 50% (Ozols, 
2003). Even though chemotherapy has been successful for treatment of some tumors 
such as testicular cancer and certain leukemia, its success rate for treatment of common 
epithelial tumors such as breast, colon, cervical, ovarian and lung has been less 
impressive (Johnstone et al., 2002). A chemotherapeutic drug used as an anti-cancer 
drug destroys the cancerous cells by interfering with the ability of the cancer cells to 
divide and reproduce. A drawback to this chemotherapeutic drug, however, is that these 
drugs also affect normal cells. 
Apoptosis is also known as programmed cell death and is a mechanism for eliminating 
unwanted cells or damaged cells. The cells initiate a suicide sequence which results in a 
quick and systematic approach in triggering cell death. It is widely believed that tumor 
cells treated with anticancer agents, including radiation, will die by apoptosis and the 
tumors that do not readily undergo apoptosis are resilient towards treatment (Lowe and 
Lin, 2000). Furthermore, response to tumor treatment that employs plant derived- 
bioactive substances in cancer patients have been implicated by apoptosis induction in 
tumor cells (Smets, 1994; Paschka et al., 1998). 
Most of the earliest pharmaceuticals were plant-derived compounds whereby plants 
have been used initially to treat diseases (Peter et al., 1998). The plant-derived drugs 
that are useful in clinical oncology include those of flavonoids, coumarins, cinnamates 
or phenolics. 
